Michael McDonald
Corporate Officer/Principal at The Royal College of Physicians
Profile
Michael McDonald is a Member of The Royal College of Physicians, where he currently holds a position.
He previously worked as a Non-Executive Director at IS Pharma Plc from 2009 to 2012, and as the Chief Medical Officer at Seagen Inc. from 2003 to 2007.
He also held the position of Chief Executive & Medical Officer at Oxford Biomedica Plc and Vice President-Clinical Research & Medical Affairs at Eli Lilly Holdings Ltd.
Dr. McDonald received his undergraduate degree from The University of Edinburgh.
Michael McDonald active positions
| Companies | Position | Start |
|---|---|---|
| The Royal College of Physicians | Corporate Officer/Principal | 2010-11-17 |
Former positions of Michael McDonald
| Companies | Position | End |
|---|---|---|
IS Pharma Plc
 IS Pharma Plc Pharmaceuticals: MajorHealth Technology IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom. | Director/Board Member | 2012-10-07 |
| SEAGEN INC. | Corporate Officer/Principal | 2007-02-28 |
Eli Lilly Holdings Ltd.
 Eli Lilly Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Holdings Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Basingstoke, UK. Founded in 1983. | Corporate Officer/Principal | - |
| OXFORD BIOMEDICA PLC | President | - |
Training of Michael McDonald
| The University of Edinburgh | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| Private companies | 3 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
IS Pharma Plc
IS Pharma Plc Pharmaceuticals: MajorHealth Technology IS Pharma Plc engages in development and commercial exploitation of healthcare products. The company develops, acquires and commercializes late stage pharmaceuticals and medical devices, focusing in critical care, oncology and neurology. Its products are Aloxi, aquoral, ContiSol, Cryogesic, Dermogesic, episil, Micelle Nanotechnology, Mysoline, OptiFlo and Variquel/Haemopressin. The company is headquartered in Chester, the United Kingdom. | Health Technology |
Eli Lilly Holdings Ltd.
Eli Lilly Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Holdings Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Basingstoke, UK. Founded in 1983. | Health Technology |
- Stock Market
- Insiders
- Michael McDonald
